Skip to content

News & Blog


Industry News: FDA Approves New HIV Drug for Adults with Limited Treatment Options

The FDA approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations.
Read More

Industry News: How New Knowledge about Cancer Is Changing Clinical Trials

Over the last two decades, biomedical researchers have begun to unravel cancer’s immense complexity, drilling down to the molecular level to better understand the genetic and biological changes that drive how cancers develop, grow, and spread.
Read More

International Thoracic Oncology Experts – ESMO Panel Discussion

ATOMIC Director Ross Camidge MD, PhD, draws out novel opinions across the field of thoracic oncology from a panel of international experts discussing their favorite ESMO abstracts from 2022.
Read More

Industry News: Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

Eating a Mediterranean diet, rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients.
Read More

Industry News: FDA Approves New Treatment Option for Patients with ALS

The FDA approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease.
Read More

Industry News: Clinical Trial Finds that Virtual Reality Therapy May Serve as Effective Adjunct to Anesthesia For Surgical Procedures

The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth's immersive virtual reality software.
Read More